Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Blood (2024) 143 (18): 1807–1815.

https://doi.org/10.1182/blood.2023022725

Published: 2024

Includes: Supplemental data

Journal Articles

Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group

Ana Marco Rico, Jose Manuel Calvo-Villas, Francisco Jose Lopez Jaime, Mariana Canaro Hinryk, Sonia Herrero-Martín, Laura Entrena Ureña, Shally Marcellini Antonio, Maria del Mar Nieto, Bolivar Diaz Jordan, Covadonga Garcia Diaz, Sergio Jurado Herrera, Faustino García Candel, Miguel Blanquer Blanquer, Pascual Marco VERA, Ihosvany Fernandez-Bello

Blood (2023) 142 (Supplement 1): 3986.

https://doi.org/10.1182/blood-2023-188412

Published: 2023

Journal Articles

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Blood (2023) 142 (Supplement 1): 5429.

https://doi.org/10.1182/blood-2023-180970

Published: 2023

Journal Articles

Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)

Blood (2023) 142 (Supplement 1): 5394.

https://doi.org/10.1182/blood-2023-182876

Published: 2023

Journal Articles

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19

Adrián Montaño, Ana Marco, Francisco José López-Jaime, Ihosvany Fernandez-Bello, Faustino García-Candel, Miguel Blanquer Blanquer, Manuel Isidro Muñoz-Pérez, Pascual Marco-Vera

Blood (2022) 140 (Supplement 1): 2778–2779.

https://doi.org/10.1182/blood-2022-166296

Published: 2022

Journal Articles

Pilot, Multicenter and Cross-Sectional Study of Joint Health in Patients with Non-Severe Hemophilia

Ihosvany Fernandez-Bello, Jose Manuel Calvo-Villas, Ana Marco, Sonia Herrero-Martín, Laura Entrena Ureña, Adrián Montaño, Francisco José López-Jaime, Bolivar Luis Diaz Jordan, Covadonga Garcia Diaz, Sergio Jurado Herrera, Noelia Pérez González, Faustino García-Candel, Miguel Blanquer Blanquer, Pascual Marco-Vera

Blood (2022) 140 (Supplement 1): 2730–2731.

https://doi.org/10.1182/blood-2022-168583

Published: 2022

Journal Articles

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Maria Cristina Pascual Izquierdo, PhD MD, Julio Del Rio-Garma, MD, Javier De La Rubia, Aurora Viejo, MD, Jesus Fernandez-Sojo, MD, Jesus Martin, MD, Xavier Solanich, MD, Faustino García-Candel, PhD MD, Luis Hernandez, MD, Marta Fernandez, MD, Ana Oliva, MD, Jose Maria Garcia-Gala, MD, Maria Eva Mingot-Castellano, PhD MD, Ines Gomez-Seguí, MD PhD, Rosa Goterris, MD, Michael Calviño, MD, María Luisa Antelo, MD PhD, Sol Sanchez, MD, Jose Antonio Moreno, MD, Cristina Amunarriz, MD, Jose Garcia-Arroba, MD, Carmen Fernandez, MD, Nieves Alonso, MD, Victoria Gonzalez, MD, Luisa Guerra, MD, M. Elena Moreno, MD, Moreno M. Dolores, MD, Gemma Moreno, MD, Melisa Daorta, MD, Esther Chica, MD, Rafael Del Orbe, MD PhD, Joan Cid, MD PhD, Margarita Berberana, MD, Carmen Ballester, MD, Sara Nistal Gil, MD, Julia Vidan, MD, Maite Calderon, MD, Consuelo Martinez Redondo, MD, Jose Carlos Hernandez, MD, Marina Gordillo, MD, Angel Salgado, Ramon Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 4910.

https://doi.org/10.1182/blood-2019-123258

Published: 2019

Journal Articles

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Blood (2019) 134 (Supplement_1): 1082.

https://doi.org/10.1182/blood-2019-122665

Published: 2019

Journal Articles

Influence of Inhibitor Characteristics on Response to Hemostatic and Immunosuppressive Treaments in Acquired Hemophilia Patients: The Ciha Project

Maria Eva Mingot, PhD MD, Pascual Marco-Vera, PhD MD, Andrés Moret, PhD MD, Carmen de Cos, MD, Faustino García-Candel, PhD MD, Raquel Garrido, MD, Jose Ramon González-Porras, MDPhD, María Fernanda López, PhD MD, Laura Quintana, MD, Ramon Rodríguez-González, MD, Ana Isabel Heiniger, MD

Blood (2017) 130 (Supplement 1): 2367.

https://doi.org/10.1182/blood.V130.Suppl_1.2367.2367

Published: 2017

Journal Articles

Platelet Reactivity in Hemophilia a. Flow Cytometry Study to Detect the Hemorragic Phenotype

Antonia Melero-Amor, Hematologist, Faustino García Candel, PhDHematologist, David García, PhD Biologist, Paola Romecin, PhDBiologist, David Iyu, PhDBiologist, Valentin Cabañas-Perianes, PhD Hematologist, Raúl Pérez, PhD Hematologist, Jose-Enrique O´Connor, PhD Biochemical, Jose M Moraleda, MD PhD, Noemí Marín, PhD, Miguel Blanquer Blanquer, MD PhD

Blood (2016) 128 (22): 4965.

https://doi.org/10.1182/blood.V128.22.4965.4965

Published: 2016

Journal Articles

Decrease of Aggregation By Platelet Impedance Aggregometry ( MULTIPLATE ) in Patients Treated with Dabigatran

Valentin Cabañas, Juan Jose Cerezo-Manchado, MD PhD, Faustino Garcia-Candel, MD PhD, Eduardo Salido, MD PhD, Raul Lopez-Perez, MD PhD, Ana Garcia-Hernandez, MD PhD, Merecedes Berenguer, MD PhD, Francesca Labbadia, MD, Miguel Blanquer Blanquer, MD PhD, Jose Maria Moraleda, MD PhD

Blood (2016) 128 (22): 5022.

https://doi.org/10.1182/blood.V128.22.5022.5022

Published: 2016

Journal Articles

Case-Control Pilot Study of the Immune Modulating Effect of FEIBA ® on Patients with Haemophilia a and Inhibitors

Ihosvany Fernandez Bello, PhD, María Teresa Álvarez Román, PhD, Victor Jiménez Yuste, PhD, Monica Martín Salces, Gemma Iruin, PhD, Santiago Bonanad, PhD, María Fernanda López Fernández, PhD, Carmen Altisent, PhD, Faustino García Candel, PhD, María Isabel Rivas Pollmar, Miguel Canales, PhD, Nora Butta, PhD

Blood (2015) 126 (23): 4688.

https://doi.org/10.1182/blood.V126.23.4688.4688

Published: 2015

NARROW

ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group

Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19

Pilot, Multicenter and Cross-Sectional Study of Joint Health in Patients with Non-Severe Hemophilia

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Factors Associated with Mortality in Patients Experiencing First Episodes of Acquired Thrombotic Thrombocytopenic Purpura (aTTP). Results of the Spanish TTP Registry

Influence of Inhibitor Characteristics on Response to Hemostatic and Immunosuppressive Treaments in Acquired Hemophilia Patients: The Ciha Project

Platelet Reactivity in Hemophilia a. Flow Cytometry Study to Detect the Hemorragic Phenotype

Decrease of Aggregation By Platelet Impedance Aggregometry ( MULTIPLATE ) in Patients Treated with Dabigatran

Case-Control Pilot Study of the Immune Modulating Effect of FEIBA ® on Patients with Haemophilia a and Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only